(1S,4aS,5R,7S,7aS)-4a,5-Dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate
- Catalog No. :
- ACOAKY392
- CAS No. :
- 19210-12-9
- Molecular Formula :
- C24H30O11
- Molecular Weight :
- 494.49
IUPAC Name:(1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg99%$112.00Login to see priceIn stockInquiry
100mg99%$164.00Login to see priceIn stockInquiry
250mg99%$276.00Login to see priceIn stockInquiry
1g99%$710.00Login to see priceIn stockInquiry
Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.
0 Reviews:View Reviews
Product Information
| Product Name | (1S,4aS,5R,7S,7aS)-4a,5-Dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate |
|---|---|
| IUPAC Name | (1S,4aS,5R,7S,7aS)-4a,5-dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl cinnamate |
| MDL No. | MFCD00017415 |
| Molecular Formula | C24H30O11 |
| Molecular Weight | 494.49 |
| SMILES | O[C@@]1(C=CO2)[C@@]([C@@H]2O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)([H])[C@](OC(/C=C/C4=CC=CC=C4)=O)(C)C[C@H]1O |
| InChI Key | KVRQGMOSZKPBNS-FMHLWDFHSA-N |
| Synonym | EN300-7357122 | BSPBio_001055 | s9171 | AB00513986 | Q-100231 | AC-34268 | BPBio1_001161 | MLS002154086 | A880338 | CHEBI:5625 | Prestwick3_000988 | Harpagoside, analytical standard | HY-N0396 | DTXSID101032528 | HARPAGOSIDE [INCI] | Harpaside | NCGC00179 |
| CAS No. | 19210-12-9 |
| PubChem CID | 5281542 |
Safety Data
- Pictogram
- Signal Word
- Warning
- Hazard Statement(s)
- H302
- Precautionary Statement(s)
- P280-P305+P351+P338

